Magazine Article | July 1, 2020

The Benefits & Challenges Of Head-To-Head Trials

Source: Life Science Leader

By Ed Miseta, Chief Editor, Clinical Leader
Follow Me On Twitter @EdClinical

Drug development generally takes a pretty standard path from discovery to commercialization. Preclinical testing leads to safety and efficacy testing in Phase 1 and Phase 2 trials. Those studies lead to a larger Phase 3 that generates data necessary to secure a regulatory approval. But there is an additional path sponsors can take that is known as head-to-head trials (H2H). These studies test your medicine against others that are already on the market, and can determine if your treatment is a better option for patients.

VIEW THE MAGAZINE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Life Science Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: